Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression

Cell

Volumn 89, Issue 3, 1997, Pages 349-356

  Laherty, Carol D ^a   Yang, Wen Ming ^b   Jian Min, Sun ^c   Davie, James R ^c   Seto, Edward ^b   Eisenman, Robert N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; DNA BINDING PROTEIN; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR; TRICHOSTATIN A;

ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION REGULATION;

MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0030969516     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80215-9     Document Type: Article

References (49)

1. Amati, B., Dalton, S., Brooks, M.W., Littlewood, T.D., Evan, G.I., and Land, H. (1992). Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359, 423-426.
2. Ayer, D.E., and Eisenman, R.N. (1993). A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7, 2110-2119.
3. Ayer, D.E., Kretzner, L., and Eisenman, R.N. (1993). Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222.
4. Ayer, D.E., Lawrence, Q.A., and Eisenman, R.N. (1995). Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776.
5. Ayer, D.E., Laherty, C.D., Lawrence, Q.A., Armstrong, A.P., and Eisenman, R.N. (1996). Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16, 5772-5781.
6. Bannister, A.J., and Kouzarides, T. (1996). The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643.
7. Blackwood, E.M., and Eisenman, R.N. (1991). Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc. Science 251, 1211-1217.
8. Blackwood, E.M., Luscher, B., and Eisenman, R.N. (1992). Myc and Max associate in vivo. Genes Dev. 6, 71-80.
9. Borrow, J., Stanton, V.P., Jr., Andresen, J.M., Becher, R., Behm, F.G., Chaganti, R.S.K., Civin, C.I., Disteche, C., Dube, I., Frischauf, A.M., et al. (1996). The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nature Genet. 14, 33-41.
10. Brasier, A.R., and Fortin, J.J., eds. (1995). Current Protocols in Molecular Biology, Vol. 3 (New York: John Wiley and Sons, Inc.).
11. Brownell, J.E., Zhou, J., Ranalli. T., Kobayashi, R., Edmondson, D.G., Roth, S.Y., and Allis, C.D. (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843-851.
12. Carmen, A.A., Rundlett, S.E., and Grunstein, M. (1996). HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. J. Biol. Chem. 271, 15837-15844.
13. Chen, J., Willingham, T., Margraf, L.R., Schreiber-Agus, N., DePinho, R.A., and Nisen, P.D. (1995). Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells. Nature Med. 1, 638-643.
14. Davie, J.R., and Hendzel, M.J. (1994). Multiple functions of dynamic histone acetylation. J. Cell. Biochem. 55, 98-105.
15. Harper, S.E., Qiu, Y., and Sharp, P.A. (1996). Sin3 corepressor function in Myc-induced transcription and transformation. Proc. Natl. Acad. Sci. USA 93, 8536-8540.
16. Heinzel, T., Lavinsky, R.M., Mullen, T.-M., Söderström, M., Laherty, C.D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S.N., Davie, J.R., et al. (1997). N-Cor, mSin3, and histone deacetylase-containing complexes in nuclear receptor and Mad repression. Nature 387, in press.
17. Hendzel, M.J., Delcuve, G.P., and Davie, J.R. (1991). Histone deacetylase is a component of the internal nuclear matrix. J. Biol. Chem. 266, 21936-21942.
18. Henriksson, M., and Lüscher, B. (1996). Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109-182.
19. Hurlin, P.J., Foley, K.P., Ayer, D.E., Eisenman, R.N., Hanahan, D., and Arbeit, J.M. (1995a). Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11, 2487-2501.
20. Hurlin, P.J., Queva, C., Koskinen, P.J., Steingrimsson, E., Ayer, D.E., Copeland, N.G., Jenkins, N.A., and Eisenman, R.N. (1995b). Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-Myc-dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14, 5646-5659.
21. Hurlin, P.J., Quéva, C., and Eisenman, R.N. (1997). Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11, 44-58.
22. Johnson, A.D. (1995). The price of repression. Cell 81, 655-658.
23. Kadosh, D., and Struhl, K. (1997). Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell, this issue.
24. Kingston, R.E., Bunker, C.A., and Imbalzano, A.N. (1996). Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev. 10, 905-920.
25. Koskinen, P.J., Ayer, D.E., and Eisenman, R.N. (1995). Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ. 6, 623-629.
26. Kretzner, L., Blackwood, E.M., and Eisenman, R.N. (1992). Myc and Max proteins possess distinct transcriptional activities. Nature 359, 426-429.
27. Lahoz, E.G., Xu, L., Schreiber-Agus, N., and DePinho, R.A. (1994). Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. Natl. Acad. Sci. USA 91, 5503-5507.
28. Mizzen, C.A., Yang, X.-J., Kokubo. T., Brownell, J.E., Bannister, A.J., Owen-Hughes, T., Workman, J., Berger, S.L., Kouzarides, T., Nakatani, Y., and Allis, C.D. (1996). The TAF 250 subunit of TFIID has histone acetyltransferase activity. Cell 87, 1261-1270.
29. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
30. Prendergast, G.C., Lawe, D., and Ziff, E.B. (1991). Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65, 395-407.
31. Rao, G., Alland, L., Guida, P., Schreiber-Agus, N., Chen, K., Chin, L., Rochelle, J.M. Seldin, M.F., Skoultchi, A.I., and DePinho, R.A. (1996). mSin3A interacts with and can functionally substitute for the amino terminal repression of the Myc antagonist Mxi1. Oncogene 12, 1165-1172.
32. Reifsnyder, C., Lowell, J., Clarke, A., and Pillus, L. (1996). Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nature Genet. 14, 42-49.
33. Roth, S.Y. (1996). Something about silencing. Nature Genet. 14, 3-4.
34. Roussel, M.F., Ashmun, R.A., Sherr, C.J., Eisenman, R.N., and Ayer, D.A. (1996). Inhibition of cell proliferation by the Mad 1 transcriptional repressor. Mol. Cell. Biol. 16, 2796-2801.
35. Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A.I., and DePinho, R.A. (1995). An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777-786.
36. Shiio, Y., Yamamoto, T., and Yamaguchi, N. (1992). Negative regulation of Rb expression by the p53 gene product. Proc. Natl. Acad. Sci. USA 89, 5206-5210.
37. Stillman, D.J., Dorland, S., and Yu, Y. (1994). Epistatic analysis of suppressor mutations that allow HO expression in the absence of the yeast SWI5 transcriptional activator. Genetics 136, 781-788.
38. Taunton, J., Hassig, C.A., and Schreiber, S.L. (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411.
39. Turner, D.L., and Weintraub, H. (1994). Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 8, 1434-1437.
40. Van Lint, C., Emiliani, S., and Verdin, E. (1996). The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Express. 5, 245-253.
41. Vidal, M., and Gaber, R.F. (1991). RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae. Mol. Cell. Biol. 11, 6317-6327.
42. Wang, H., and Stillman, D.J. (1993). Transcriptional repression in Saccaromyces cerevisiae by a SIN3-LexA fusion protein. Mol. Cell. Biol. 13, 1805-1814.
43. Wang, H., Clark, I., Nicholon, P.R., Herskowitz, I., and Stillman, D.J. (1990). The Saccaromyces cerevisiae SIN3 gene, a negative regulator of HO, contains four paired amphipathic helix motifs. Mol. Cell. Biol. 10, 5927-5936.
44. Wolffe, A.P. (1996). Histone deacetylase: a regulator of transcription. Science 272, 371-372.
45. Wolffe, A.P., and Pruss, D. (1996). Targeting chromatin disruption: transcription regulators that acetylate histones. Cell 84, 817-819.
46. Yang, W.-M., Inouye, C., Zeng, Y., Bearss, D., and Seto, E. (1996a). Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 93, 12845-12850.
47. Yang, X.-J., Ogryzko, V.V., Nishikawa, J., Howard, B.H., and Nakatani, Y. (1996b). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.
48. Yoshida, M., Horinouchi, S., and Beppu, T. (1995).Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423-430.
49. Zervos, A.S., Gyuris, J., and Brent, R. (1993). Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232.